Concomitant Monitoring ofWT1andFLT3-ITDexpression inFLT3-ITDacute Myeloid Leukemia Patients: Which Should We Trust as a Minimal Residual Disease Marker?

American Journal of Hematology - United States
doi 10.1002/ajh.24686
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley


Related search